Daniel Swisher
Chairman at CERUS CORPORATION
Net worth: 7 M $ as of 2024-03-30
Profile
Mr. Daniel N. Swisher is a President & Chief Operating Officer at Jazz Pharmaceuticals Plc, a President & Chief Operating Officer at Jazz Pharmaceuticals, Inc., an Independent Director at Corcept Therapeutics, Inc. and a Chairman at Cerus Corp. He is on the Board of Directors at Corcept Therapeutics, Inc. Mr. Swisher was previously employed as a President, CEO, Secretary & Director by Sunesis Pharmaceuticals, Inc. and a Senior Vice President-Sales & Marketing by ALZA Corp. He received his undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-30 | 55,014 ( 0.09% ) | 7 M $ | 2024-03-30 | |
CERUS CORPORATION
0.06% | 2023-06-06 | 104,545 ( 0.06% ) | 197 590 $ | 2024-03-30 |
| 2023-10-25 | 0 ( -.--% ) | - $ | 2024-03-30 | |
| 2024-03-31 | 0 ( -.--% ) | - $ | 2024-03-30 |
Daniel Swisher active positions
| Companies | Position | Start |
|---|---|---|
| CERUS CORPORATION | Chairman | 2013-09-30 |
| CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 2015-06-17 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 2023-10-25 |
Former positions of Daniel Swisher
| Companies | Position | End |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | President | 2023-09-30 |
| VIRACTA THERAPEUTICS, INC. | Chief Executive Officer | 2017-12-30 |
| ALZA CORPORATION | Sales & Marketing | 2001-08-31 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | President | - |
Training of Daniel Swisher
| Yale University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| CERUS CORPORATION | Health Technology |
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private companies | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Daniel Swisher
